Linked Life Data

15803021

Source:http://linkedlifedata.com/resource/pubmed/id/15803021

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2005-4-1
pubmed:abstractText
There is a potential interface between osteoporosis and the chronic inflammation of inflammatory bowel disease (IBD), and the osteoprotegerin (OPG)/receptor for activated nuclear factor-kappaB (RANK)/RANK ligand (RANKL) signaling pathway may be an important mediator, although data are limited.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids, http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Osteoprotegerin, http://linkedlifedata.com/resource/pubmed/chemical/RANK Ligand, http://linkedlifedata.com/resource/pubmed/chemical/Receptor Activator of Nuclear..., http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cytoplasmic and Nuclear, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor, http://linkedlifedata.com/resource/pubmed/chemical/TNFRSF11A protein, human, http://linkedlifedata.com/resource/pubmed/chemical/TNFRSF11B protein, human, http://linkedlifedata.com/resource/pubmed/chemical/TNFSF11 protein, human
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1078-0998
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
325-30
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15803021-Adult, pubmed-meshheading:15803021-Carrier Proteins, pubmed-meshheading:15803021-Case-Control Studies, pubmed-meshheading:15803021-Colitis, Ulcerative, pubmed-meshheading:15803021-Crohn Disease, pubmed-meshheading:15803021-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:15803021-Estrogen Replacement Therapy, pubmed-meshheading:15803021-Female, pubmed-meshheading:15803021-Glucocorticoids, pubmed-meshheading:15803021-Glycoproteins, pubmed-meshheading:15803021-Humans, pubmed-meshheading:15803021-Male, pubmed-meshheading:15803021-Membrane Glycoproteins, pubmed-meshheading:15803021-Middle Aged, pubmed-meshheading:15803021-Osteoprotegerin, pubmed-meshheading:15803021-RANK Ligand, pubmed-meshheading:15803021-Receptor Activator of Nuclear Factor-kappa B, pubmed-meshheading:15803021-Receptors, Cytoplasmic and Nuclear, pubmed-meshheading:15803021-Receptors, Tumor Necrosis Factor, pubmed-meshheading:15803021-Sex Factors, pubmed-meshheading:15803021-Smoking
pubmed:year
2005
pubmed:articleTitle
Serum osteoprotegerin is increased in Crohn's disease: a population-based case control study.
pubmed:affiliation
Department of Medicine, University of Manitoba, Manitoba, Canada. cbernst@cc.umanitoba.ca
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't